BluePath Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-310	Closed	-$34.9K	–	245
2023 Q3	$34.9K	Buy	+310	New	+$34.9K	0.03%	223